Related Experiment Videos
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Tadashi Yamashita1, Akira Hashiramoto, Martin Haluzik
1Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892, USA.
Summary
Mice lacking GM3 synthase, a key molecule in cell membranes, showed increased insulin sensitivity and protection against diet-induced insulin resistance. This suggests GM3 ganglioside negatively regulates insulin signaling, offering a potential target for type 2 diabetes treatments.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Gangliosides, sialic acid-containing glycosphingolipids, are crucial for cell recognition and signaling.
- GM3 ganglioside is a fundamental glycosphingolipid found in mammalian plasma membranes.
Purpose of the Study:
- To investigate the role of GM3 ganglioside in insulin signaling.
- To determine if GM3 synthase deficiency impacts insulin sensitivity and resistance.
Main Methods:
- Generation of GM3 synthase-deficient mutant mice.
- Assessment of insulin sensitivity and insulin receptor phosphorylation in mutant mice.
- Evaluation of protection against high-fat diet-induced insulin resistance.
Main Results:
- GM3 synthase-deficient mice exhibited heightened insulin sensitivity.
- Enhanced insulin receptor phosphorylation was observed in the skeletal muscle of mutant mice.
- Mutant mice were protected from high-fat diet-induced insulin resistance.
Conclusions:
- GM3 ganglioside acts as a negative regulator of insulin signaling.
- Targeting GM3 ganglioside synthesis may offer a therapeutic strategy for type 2 diabetes.
- GM3 deficiency confers protection against metabolic dysfunction.